Spectral Med Stock Fundamentals
| EDTXF Stock | USD 0.42 0.07 20.00% |
Spectral Med fundamentals help investors to digest information that contributes to Spectral Med's financial success or failures. It also enables traders to predict the movement of Spectral Pink Sheet. The fundamental analysis module provides a way to measure Spectral Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Spectral Med pink sheet.
Spectral |
Spectral Med Company Current Valuation Analysis
Spectral Med's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Spectral Med Current Valuation | 65.99 M |
Most of Spectral Med's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Spectral Med is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Spectral Med has a Current Valuation of 65.99 M. This is 99.54% lower than that of the Biotechnology sector and 99.15% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.6% higher than that of the company.
Spectral Med Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spectral Med's current stock value. Our valuation model uses many indicators to compare Spectral Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spectral Med competition to find correlations between indicators driving Spectral Med's intrinsic value. More Info.Spectral Med is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Spectral Med's earnings, one of the primary drivers of an investment's value.Spectral Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Spectral Med's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Spectral Med could also be used in its relative valuation, which is a method of valuing Spectral Med by comparing valuation metrics of similar companies.Spectral Med is currently under evaluation in current valuation category among its peers.
Spectral Fundamentals
| Return On Equity | -7.84 | |||
| Return On Asset | -0.74 | |||
| Operating Margin | (6.38) % | |||
| Current Valuation | 65.99 M | |||
| Shares Outstanding | 278.22 M | |||
| Shares Owned By Insiders | 20.43 % | |||
| Shares Owned By Institutions | 13.18 % | |||
| Price To Earning | (13.69) X | |||
| Price To Book | 51.73 X | |||
| Price To Sales | 42.75 X | |||
| Revenue | 2.05 M | |||
| Gross Profit | 1.22 M | |||
| EBITDA | (8.46 M) | |||
| Net Income | (8.79 M) | |||
| Cash And Equivalents | 3.47 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 537 K | |||
| Debt To Equity | 0.26 % | |||
| Current Ratio | 2.38 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (8.7 M) | |||
| Earnings Per Share | (0.03) X | |||
| Target Price | 1.24 | |||
| Number Of Employees | 31 | |||
| Beta | 0.99 | |||
| Market Capitalization | 66.02 M | |||
| Total Asset | 11.55 M | |||
| Retained Earnings | (51.99 M) | |||
| Working Capital | 4.36 M | |||
| Current Asset | 6.33 M | |||
| Current Liabilities | 1.96 M | |||
| Z Score | 67.6 | |||
| Net Asset | 11.55 M |
About Spectral Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Spectral Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spectral Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spectral Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada. SPECTRAL MEDICAL operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 31 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Spectral Pink Sheet
Spectral Med financial ratios help investors to determine whether Spectral Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.